Medical News

RSS

Aspyra announces Q2 financial results for the year 2009

Aspyra, Inc. (AMEX: APY), a provider of clinical and diagnostic information systems for the healthcare industry, today reported its results of operations for the second quarter ended June 30, 2009.

20 Aug 2009

Compirion Healthcare Solutions webinar for improving hospital emergency department standards

A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.

20 Aug 2009

H1N1 vaccine administration coverage for eligible members of Anthem Blue Cross and Blue Shield in Maine

Anthem Blue Cross and Blue Shield in Maine has announced that it will offer coverage for the administration of the H1N1 (swine flu) vaccine when it becomes commercially available to the general public. The vaccine administration will be covered for members whose benefit plans provide coverage for vaccines.

20 Aug 2009

National Science Foundation funds CMU for developing revolutionary computational tools

A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create revolutionary computational tools that will advance science on a broad array of fronts, from discovering new cancer treatments to designing safer aircraft.

20 Aug 2009

Advansource Biomaterials partners with medical device company for the development of specialized solution-based polymer

AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced that the Company has entered into a multi-year development agreement with a leading international medical device company.

20 Aug 2009

Anthem Media Group acquires Ascend Media's Allied Healthcare division

Anthem Media Group (AMG) announced today its acquisition of Ascend Media's Los Angeles-based medical media division for an undisclosed sum. The news comes just days after Inc. Magazine named the Kansas City-based Anthem one of the nation's fastest-growing companies.

20 Aug 2009

Financial results for third-quarter 2009 to be announced by Martek Biosciences

Martek Biosciences Corporation (Nasdaq: MATK) announced that it intends to release the results of its third quarter of fiscal 2009 on September 2, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference call to discuss these results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.

20 Aug 2009

Dey's Albuterol Sulfate Inhalation Solution lots stolen in Texas

Dey L.P., a subsidiary of Mylan Inc., today issued an advisory regarding two lots of its Albuterol Sulfate Inhalation Solution, 0.083%, unit-dose vials. The lots were on a tractor-trailer that was stolen in McKinney, Texas.

20 Aug 2009

Jim Monton appointed to GeneLink's Board of Directors

GeneLink, Inc., has appointed Jim Monton to the Company’s Board of Directors. Mr. Monton brings decades of product development and branding experience, both domestic and international, in health and beauty care for Procter & Gamble (P&G). Jim will serve on the Audit and Compensation Committees of the Board of Directors.

20 Aug 2009

DNA-encased carbon nanotubes used for treating human prostate cancer tumors in mice

Researchers at Wake Forest University School of Medicine have destroyed prostate cancer tumors in mice by injecting them with specially-coated, miniscule carbon tubes and then superheating the tubes with a brief zap of a laser.

20 Aug 2009

Cardiovascular Systems' revenues in fourth-quarter of 2009 increases to $15.7 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fourth quarter and fiscal year ended June 30, 2009.

19 Aug 2009

AMDL reports revenues of $3.2 million for second quarter of 2009

AMDL Inc., a US-based pharmaceutical company with major operations in China, today reported unaudited results and the filing of its Form 10-Q with the Securities and Exchange Commission ("SEC") for fiscal second quarter 2009.

19 Aug 2009

African Americans receive less mental illness treatments and diagnoses than Caucasian Americans

According to the Surgeon General, only one-third of Americans with a mental health problem seek treatment; the percentage of African Americans getting help is only half that of non-Hispanic whites.

19 Aug 2009

Brits risk late cancer diagnosis because of poor symptom awareness

One in seven people cannot name a single symptom of cancer, according to a Cancer Research UK survey published Monday.

19 Aug 2009

Steroid hormones found to affect gene activity

Intermittent signaling by steroid hormones can affect the way genes are expressed in rodents, according to research by scientists at the University of Bristol and the National Cancer Institute (NCI), USA. This work has major implications for understanding how steroids work and opens novel avenues for new therapies.

19 Aug 2009

Nano-bio material kills cancer cells, leaves healthy cells in unharmed

Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

19 Aug 2009

Phrma brushes off Republican leader's attacks

"The prescription drug industry's lobbying arm is defending its deal with President Barack Obama in the wake of criticism from House Minority Leader John Boehner, who charged it with 'appeasing' the Obama administration," The Hill reports.

19 Aug 2009

Intracacies of doctors' fees difficult to unravel

"For the most part, doctor fees are a mystery. If people see a doctor who is part of their insurance network, they are responsible only for deductibles and co-payments, and the price the health insurer pays is often a secret," The New York Times reports. "And if people see a doctor outside their network, they usually have no idea what the charge will be - even though they are responsible for most of it - until the bill comes."

19 Aug 2009

Mullti-million dollar ad campaigns supporting health overhaul launched

Various advertising campaigns take to the airwaves. Among their messages are the moral imperative of reform and the importance of cooperation.

19 Aug 2009

FDA approves Hiberix Haemophilus influenzae type b vaccine

In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.

19 Aug 2009